학술논문
BIG BANG study (EPOC1703): multicentre, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy with binimetinib, encorafenib and cetuximab in patients with BRAF non-V600E mutated metastatic colorectal cancer
Document Type
Article
Author
Kotani, Daisuke; Bando, Hideaki; Taniguchi, Hiroya; Masuishi, Toshiki; Komatsu, Yoshito; Yamaguchi, Kensei; Nakajima, Takako; Satoh, Taroh; Nishina, Tomohiro; Esaki, Taito; Nomura, Shogo; Takahashi, Koji; Iida, Shinobu; Matsuda, Seiko; Motonaga, Shinya; Fuse, Nozomu; Sato, Akihiro; Fujii, Satoshi; Ohtsu, Atsushi; Ebi, Hiromichi; Yoshino, Takayuki
Source
In ESMO Open 2020 5(1)
Subject
Language
ISSN
2059-7029